Cited by 39COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research

Inflammatory profiles and clinical features of coronavirus 2019 survivors 3 months after discharge in Wuhan, China.

Open access
Zhou, Mei, Yin, Zhengrong, Xu, Juanjuan, Wang, Sufei, Liao, Tingting, Wang, Kai, Li, Yumei, Yang, Fan +4 more·2021·The Journal of Infectious Diseases

Abstract

Background: Postdischarge immunity and its correlation with clinical features among patients recovered from coronavirus disease 2019(COVID-19) are poorly described. This prospective cross-sectional study explored the inflammatory profiles and clinical recovery of patients with COVID-19 at 3 months after hospital discharge. Methods: Patients with COVID-19 discharged from 4 hospitals in Wuhan, recovered asymptomatic patients (APs) from an isolation hotel, and uninfected healthy controls (HCs) were recruited. Viral nucleic acid and antibody detection, laboratory examination, computed tomography, pulmonary function assessment, multiplex cytokine assay, and flow cytometry were performed. Results: The72 age-, sex- and body mass index–matched participants included 19 patients with severe/critical COVID-19 (SPs), 20 patients with mild/moderate COVID-19 (MPs), 16 APs, and 17 HCs. At 3 months after discharge, levels of proinflammatory cytokines and factors related to vascular injury/repair in patients recovered from COVID-19 had not returned to those of the HCs, especially among recovered SPs compared with recovered MPs and APs. These cytokines were significantly correlated with impaired pulmonary function and chest computed tomographic abnormalities. However, levels of immune cells had returned to nearly normal levels and were not significantly correlated with abnormal clinical features. Conclusion: Vascular injury, inflammation, and chemotaxis persisted in patients with COVID-19 and were correlated with abnormal clinical features 3 months after discharge, especially in recovered SPs.

Integrity signals

Registry

Crossref · 10.1093/infdis/jiab181

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhou, M., Yin, Z., Xu, J., Wang, S., Liao, T., Wang, K., Li, Y., Yang, F., Wang, Z., Yang, G., Zhang, J., & Jin, Y.
Affiliations
  • Wuhan Union Hospital (CN)
  • Huazhong University of Science and Technology (CN)
  • Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Venue
The Journal of Infectious Diseases
Published
2021-04-04
Volume
224
Issue
9
Pages
1473-1488
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W3147374446
Cited by
39
References
29
Citations by year
2025: 2 · 2024: 4 · 2023: 11 · 2022: 15 · 2021: 7
FWCI
2.93
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (82041018)
  • National Major Science and Technology Projects of China (2019ZX09301001)
  • Ministry of Science and Technology of the People's Republic of China (2020YFC0844300)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, inflammatory cytokines, vascular injury, lung function, chest CT abnormalities, long-term clinical outcomes
MeSH terms
COVID-19, SARS-CoV-2, Aftercare, Anti-Bacterial Agents, Antiviral Agents, China, Cross-Sectional Studies, Humans, Patient Discharge, Prospective Studies, Retrospective Studies, Cytokines, Treatment Outcome, Survivors, Vascular System Injuries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review